Karwacki Marek W
Coordinated Medical Care Center for Neurofibromatoses and related RASopathies, Department of Pediatrics, Hematology and Oncology, Medical University of Warsaw, Warsaw, Poland.
Contemp Oncol (Pozn). 2020;24(2):140-144. doi: 10.5114/wo.2020.97637. Epub 2020 Jul 3.
The main goal of this study was to draw the attention of physicians to commonly undisclosed risk of breast cancer (BrCa) in women suffering from neurofibromatosis type 1 (NF-1), which is 5-fold higher than in the general population. NF-1 related BrCa arises earlier (< 50 years) and is more advanced, with an increased mortality. NF-1 is one of the most frequent monogenic diseases worldwide and a tumor predisposition syndrome. The gene is an important negative regulator of the Ras oncogene and belongs to the family of the 12 the most important BrCa predisposition genes. Planning introduction of BrCa screening guidelines for NF-1 women in Poland we started with assessment of BrCa risk awareness and current preventive practices in this population by a survey published in an open access internet profile dedicated exclusively to patients with NF-1 in Poland, with 1928 participants. As a result, we revealed that the awareness of this specific risk was declared by only 30% out of 138 responders, and only 21% of them received this information from medical professionals. In all 4 (2.89%) women suffering from BrCa the cancer was diagnosed before the 50 year of age. It exceeds significantly the expected prevalence of BrCa in the general population of Polish women. We conclude that the limited awareness of NF-1 related BrCa risk in Polish patients warrants the educational effort directed both to the NF-1 patients by professional counseling and to the medical community, in order to increase the efficacy of preventive measures and decrease BrCa mortality.
本研究的主要目的是引起医生对1型神经纤维瘤病(NF-1)女性中常见的未公开的乳腺癌(BrCa)风险的关注,该风险比普通人群高5倍。与NF-1相关的BrCa发病较早(<50岁)且病情更严重,死亡率更高。NF-1是全球最常见的单基因疾病之一,也是一种肿瘤易感性综合征。该基因是Ras癌基因的重要负调控因子,属于12个最重要的BrCa易感基因家族。在波兰计划为NF-1女性引入BrCa筛查指南时,我们首先通过在波兰一个专门为NF-1患者设立的开放获取互联网平台上发布的一项调查,评估了该人群对BrCa风险的认识和当前的预防措施,共有1928名参与者。结果显示,在138名受访者中,只有30%的人表示知晓这一特定风险,其中只有21%的人从医疗专业人员那里获得了这一信息。在所有4名(2.89%)患有BrCa的女性中,癌症在50岁之前被诊断出来。这显著超过了波兰女性普通人群中BrCa的预期患病率。我们得出结论,波兰患者对与NF-1相关的BrCa风险认识有限,因此有必要通过专业咨询对NF-1患者和医疗界进行教育,以提高预防措施的效果并降低BrCa死亡率。